Taiwan News: The Technology Department of the Ministry of Economic Affairs has supported scientific and technological research and development in the field of biomedicine over the years. A total of 25 biomedical research and development results have been exhibited recently. There is an "interactive simulation" area for on-site interactive experience at the event site. The “Healthy Defense” area, the “lightly invasive and fast healing” area that can greatly reduce patient discomfort and speed up recovery, and the four major areas of “scientific drug and new drug development”. Among them, the "Interactive Simulation" area exhibited the "Sensory Sports Health Guidance System", which can guide users to continue to exercise through the game, and simultaneously monitor and analyze physiological information; in the "Health Guard" area "sperm vitality sorting system" use Automated screening to reduce judgment errors in manual selection and improve the success rate of conception; the "actionable negative pressure wound care system" exhibited in the "lightly invasive and fast healing" area requires small and light weight, improving comfort and convenience and promoting wound healing. It can continue to care for wounds at home or outdoors; the "cerebral nerve molecular contrast agent" in the "Scientific Drugs and New Drug Development" area can be used to diagnose Parkinson's syndrome, take care of Chinese people's health, and demonstrate the development of new technologies for people's livelihood in the Ministry of Economic Affairs. People's living needs, creating healthy and comfortable goals.

Home sleep abnormality monitor

Taibo and the Industrial Technology Research Institute have jointly redesigned the sensor with the core technology of sleep detection, and developed home sleep abnormality monitors such as physiological electrical signals (electro-oculograms), which can be used for disease assessment, efficacy tracking and cardiovascular Assessment of risk of onset.

To guide users to exercise to achieve fitness and fitness improvement in an interesting and novel interactive way, thereby maintaining physical fitness and muscle endurance; in addition, assist health managers to find empirical and effective sports models for individuals, and promote their application to sports health management.

To guide users to exercise to achieve fitness and fitness improvement in an interesting and novel interactive way, thereby maintaining physical fitness and muscle endurance; in addition, assist health managers to find empirical and effective sports models for individuals, and promote their application to sports health management.

Lin Quanneng, director of the Technology Department of the Ministry of Economic Affairs, said that in recent years, with the efforts of consortium research institutions and industry technology projects, there have been flowering glory everywhere, whether in medical equipment or biotech medicine. More than 10 important achievements were exhibited in the medical equipment section this time, with the purpose of improving people's healthy life and promoting happy life. For example, the Institute of Industrial Technology transferred the "negative pressure wound care products that can be taken away" to the company. Transferred "Minimally Invasive Crest Surgery" to Ytterbium Titanium Co., Ltd. and Taibo Co., Ltd. to develop "Sleep Abnormality Monitor", and another plastic center transferred "Titanium Clip Hemostatic Forceps" to Renqi Enterprises, Metal Center and Keding Co. "Slow speed molar grinding machine", etc., all effectively improve the patient's quality of life through technology.

In addition, the intestinal scanning mirror developed by the Chinese Academy of Sciences with complementary metal oxide semiconductor (CMOS) technology and image processing technology, Benstar Group ’s Besta and Mingda companies use their optical image energy to develop portable ultrasound and fundus cameras, etc. Guide cross-domain energy into medical equipment. In June of this year, the Plastic Center transferred the technology of “inflating fixed splints quickly within 10 seconds” to Huayi Medical Instrument Technology Co., Ltd. This product can be used as an emergency aid package for general families, schools and other public places, except for emergency aid units. This type of disposable inflatable splint product is more convenient and safer than the current repeated disinfection splint. It is estimated that it can create an output value of NT $ 700 million; the above are the accumulated R & D of the effective use of various technology projects by the Technology Department of the Ministry of Economic Affairs Energy, strengthen the enterprise's innovative R & D energy, induce industry R & D investment, and enhance the overall industrial competitiveness.

Lin Quanneng said that in terms of the development of new drugs and generic drugs, the Ministry of Economic Affairs has long supported the anticancer drugs and multiple sclerosis drugs developed by the Institute of Industrial Technology, the Biotechnology Center and the Chinese Academy of New Drugs and Nuclear Energy Research Institute. Contrast agents are the driving force and source of innovation for the new drug industry in the future. The "polymer nanocell material and drug coating technology" developed by the Industrial Technology Research Institute was transferred to Jingde Pharmaceutical Co., Ltd. of Tai Ni Enterprise Group to develop a breakthrough in new anti-cancer drugs for the Chinese, so that China can master the key independent technologies of new drugs To further drive the domestic upstream, midstream and downstream related industrial chains, and to attack the market of new formulations of nano-anticancer drugs of $ 14 billion.

In addition, Director Lin Quanneng also emphasized that the Technology Department of the Ministry of Economic Affairs has carried out 7 years of "fast track clinical trial plan (fast track)" to subsidize manufacturers to implement clinical trials of new drugs, a total of 47, including 10 in Phase III, such as Kea PI-88 anticancer drug is the world's first new drug to prevent recurrence of liver cancer after surgery. It is now in clinical phase III trials in major medical centers around the world. Nerofloxacin developed by Taijing Biotechnology Co. In the third phase of the trial, the results are worth looking forward to.

A total of 31 product developments were subsidized by the "Scientific Medicine Internationalized Multiplied Output Value Policy Project" part of the manufacturer's product development, targeting international marketing, which is expected to generate more than 16.5 billion yuan in output value. For example, Xinghui Pharmaceutical Company has invested in the construction of a second cancer preparation plant. The production capacity can reach 5 million doses per year. In addition, Taiwan Shenlong Company will invest 1.1 billion yuan to build a cancer injection plant that meets international GMP, and rush to attack the global tens of billions of dollars of cancer injection market. Taiwan's pharmaceutical industry is just around the corner.

Home Appliances

SHENZHEN CHONDEKUAI TECHNOLOGY CO.LTD , https://www.szsiheyi.com